000 01655 a2200385 4500
005 20250516103037.0
264 0 _c20130107
008 201301s 0 0 eng d
022 _a1879-355X
024 7 _a10.1016/j.ijrobp.2012.05.019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAtaman, Ozlem U
245 0 0 _aThe clinical development of molecularly targeted agents in combination with radiation therapy: a pharmaceutical perspective.
_h[electronic resource]
260 _bInternational journal of radiation oncology, biology, physics
_cNov 2012
300 _ae447-54 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aClinical Trials as Topic
_xstatistics & numerical data
650 0 4 _aClinical Trials, Phase I as Topic
_xstatistics & numerical data
650 0 4 _aClinical Trials, Phase II as Topic
_xstatistics & numerical data
650 0 4 _aClinical Trials, Phase III as Topic
_xstatistics & numerical data
650 0 4 _aCombined Modality Therapy
_xmethods
650 0 4 _aDrug Industry
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aNeoplasms
_xmortality
650 0 4 _aRadiotherapy
_xmethods
650 0 4 _aResearch Support as Topic
_xstatistics & numerical data
700 1 _aSambrook, Sally J
700 1 _aWilks, Chris
700 1 _aLloyd, Andrew
700 1 _aTaylor, Amanda E
700 1 _aWedge, Stephen R
773 0 _tInternational journal of radiation oncology, biology, physics
_gvol. 84
_gno. 4
_gp. e447-54
856 4 0 _uhttps://doi.org/10.1016/j.ijrobp.2012.05.019
_zAvailable from publisher's website
999 _c21963488
_d21963488